ALEVATE Trademark

Trademark Overview


On Tuesday, May 17, 2022, a trademark application was filed for ALEVATE with the United States Patent and Trademark Office. The USPTO has given the ALEVATE trademark a serial number of 79350535. The federal status of this trademark filing is REGISTERED as of Tuesday, December 3, 2024. This trademark is owned by Albumedix Ltd. The ALEVATE trademark is filed in the Education & Entertainment Services, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Education, namely, classes, seminars, and workshops in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals, and chemical analysis; providing of training in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals, and chemical analysis; teaching and training in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals and chemical analysis; teaching and training in the fields of development and use of vaccines, growth factors, immune modulators, monoclonal antibodies, cells, cell therapies, tissues, proteins, recombinant proteins, nucleic acids, gene therapies, products derived from living culture systems, products derived from human blood, products derived from plasma; provision of medical, biological, biopharmaceutical, pharmaceutical and chemical instruction courses; organization of educational conferences in the fields of medical, biological, biopharmaceutical, pharmaceutical and chemical research and de...

Regulatory compliance auditing; regulatory compliance consultancy in the field of biotechnology, pharmaceuticals, biopharmaceuticals, and medical testing and research; reviewing standards and practices to assure compliance with laws and regulations in the fields of biology, pharmaceuticals, biopharmaceuticals, chemicals, and medicine; information, consultancy and advisory services for the aforementioned services

Research and development services in the field of new biological, pharmaceutical, biopharmaceutical, chemical and medical products; technological consultancy, namely, providing consultancy and expert assistance in the field of new product development of medicines and pharmaceutical products, and laboratory analysis in the field of medicines and pharmaceuticals; research, development and laboratory analysis services relating to pharmaceutical and medicinal goods, in particular, albumin, chemicals, peptides, proteins, antibodies, cells, nucleic acids, viruses, live viruses, live-attenuated viruses, attenuated viruses, virus-like particles and viral vectors; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control in the field of pharmaceutical, biopharmaceutical, chemical, and medical products; certification, namely, quality control services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; c...
alevate

General Information


Serial Number79350535
Word MarkALEVATE
Filing DateTuesday, May 17, 2022
Status700 - REGISTERED
Status DateTuesday, December 3, 2024
Registration Number7582839
Registration DateTuesday, December 3, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 1, 2024

Trademark Statements


Goods and ServicesEducation, namely, classes, seminars, and workshops in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals, and chemical analysis; providing of training in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals, and chemical analysis; teaching and training in the fields of biology, medicine, biologicals, biopharmaceuticals, pharmaceuticals and chemical analysis; teaching and training in the fields of development and use of vaccines, growth factors, immune modulators, monoclonal antibodies, cells, cell therapies, tissues, proteins, recombinant proteins, nucleic acids, gene therapies, products derived from living culture systems, products derived from human blood, products derived from plasma; provision of medical, biological, biopharmaceutical, pharmaceutical and chemical instruction courses; organization of educational conferences in the fields of medical, biological, biopharmaceutical, pharmaceutical and chemical research and development; technical training in the field of medical, biological, biopharmaceutical, pharmaceutical and chemical analysis; information, consultancy and advisory services for the aforementioned services
Goods and ServicesRegulatory compliance auditing; regulatory compliance consultancy in the field of biotechnology, pharmaceuticals, biopharmaceuticals, and medical testing and research; reviewing standards and practices to assure compliance with laws and regulations in the fields of biology, pharmaceuticals, biopharmaceuticals, chemicals, and medicine; information, consultancy and advisory services for the aforementioned services
Goods and ServicesResearch and development services in the field of new biological, pharmaceutical, biopharmaceutical, chemical and medical products; technological consultancy, namely, providing consultancy and expert assistance in the field of new product development of medicines and pharmaceutical products, and laboratory analysis in the field of medicines and pharmaceuticals; research, development and laboratory analysis services relating to pharmaceutical and medicinal goods, in particular, albumin, chemicals, peptides, proteins, antibodies, cells, nucleic acids, viruses, live viruses, live-attenuated viruses, attenuated viruses, virus-like particles and viral vectors; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control in the field of pharmaceutical, biopharmaceutical, chemical, and medical products; certification, namely, quality control services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; certification, namely, quality assurance services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; process monitoring, namely, quality assurance in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; quality control services for others in the field of development and testing of cells; services of a scientific chemical and biological laboratory; development and testing of chemical, pharmaceutical, biopharmaceutical, chemical, and medical production methods; quality control services for others and authentication services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; process monitoring, namely, providing quality assurance services in the field of biological, pharmaceutical, biopharmaceutical, chemical, and medical products; scientific and medical laboratory services; information, consultancy and advisory services for research, testing, and development in the pharmaceutical, biopharmaceutical, chemical, and medical fields, none of the foregoing related to financial software

Classification Information


International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateFriday, September 23, 2022
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 23, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 23, 2022
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAlbumedix Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameAlbumedix Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameAlbumedix Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Friday, September 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 22, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, September 27, 2022APPLICATION FILING RECEIPT MAILED
Sunday, January 29, 2023NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, March 7, 2023ASSIGNED TO EXAMINER
Wednesday, March 15, 2023NON-FINAL ACTION WRITTEN
Thursday, March 16, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, April 2, 2023NEW REPRESENTATIVE AT IB RECEIVED
Thursday, May 4, 2023REFUSAL PROCESSED BY MPU
Thursday, May 4, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, May 24, 2023REFUSAL PROCESSED BY IB
Friday, November 3, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 3, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 3, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, December 31, 2023FINAL REFUSAL WRITTEN
Sunday, December 31, 2023FINAL REFUSAL E-MAILED
Sunday, December 31, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 28, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 28, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, March 18, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Monday, June 24, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, June 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 28, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 1, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 1, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 3, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, December 3, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, March 3, 2025FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB